1. Home
  2. FPF vs HROW Comparison

FPF vs HROW Comparison

Compare FPF & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPF
  • HROW
  • Stock Information
  • Founded
  • FPF 2013
  • HROW 1998
  • Country
  • FPF United States
  • HROW United States
  • Employees
  • FPF N/A
  • HROW N/A
  • Industry
  • FPF Trusts Except Educational Religious and Charitable
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPF Finance
  • HROW Health Care
  • Exchange
  • FPF Nasdaq
  • HROW Nasdaq
  • Market Cap
  • FPF 1.1B
  • HROW 1.1B
  • IPO Year
  • FPF N/A
  • HROW N/A
  • Fundamental
  • Price
  • FPF $18.83
  • HROW $36.19
  • Analyst Decision
  • FPF
  • HROW Strong Buy
  • Analyst Count
  • FPF 0
  • HROW 7
  • Target Price
  • FPF N/A
  • HROW $61.83
  • AVG Volume (30 Days)
  • FPF 186.7K
  • HROW 439.2K
  • Earning Date
  • FPF 01-01-0001
  • HROW 08-06-2025
  • Dividend Yield
  • FPF 8.08%
  • HROW N/A
  • EPS Growth
  • FPF N/A
  • HROW N/A
  • EPS
  • FPF N/A
  • HROW N/A
  • Revenue
  • FPF N/A
  • HROW $212,858,000.00
  • Revenue This Year
  • FPF N/A
  • HROW $44.89
  • Revenue Next Year
  • FPF N/A
  • HROW $38.22
  • P/E Ratio
  • FPF N/A
  • HROW N/A
  • Revenue Growth
  • FPF N/A
  • HROW 53.49
  • 52 Week Low
  • FPF $13.91
  • HROW $20.85
  • 52 Week High
  • FPF $18.09
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • FPF 58.52
  • HROW 62.46
  • Support Level
  • FPF $18.71
  • HROW $35.27
  • Resistance Level
  • FPF $18.83
  • HROW $37.74
  • Average True Range (ATR)
  • FPF 0.13
  • HROW 1.81
  • MACD
  • FPF -0.03
  • HROW 0.17
  • Stochastic Oscillator
  • FPF 65.79
  • HROW 73.31

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: